People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ajax Therapeutics, Inc. | — | Biotechnology | Series C | $140.4M | $907.9M | 2021 |
| Kumquat Biosciences Inc | — | Biotechnology | Series C | $135.9M | $816.6M | 2021 |
Scott Platshon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Platshon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| David Schnell | 1 | 7 |
| Ramy Farid | 1 | 5 |
| YI LIU | 1 | 4 |
| PINGDA REN | 1 | 3 |
| Martin Vogelbaum | 1 | 3 |
| Ross Levine | 1 | 1 |
| Lynn Yang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.